BeOne Medicines Ltd.
BeOne Medicines Ltd. (ONC) Stock Overview
Explore BeOne Medicines Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
39.6B
P/E Ratio
582.01
EPS (TTM)
$0.51
ROE
0.02%
ONC Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of BeOne Medicines Ltd. (ONC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 66.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $422.04.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 582.01 and a market capitalization of 39.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.